Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in the Liver of Young Rats

Roberts, 2007, Pediatric nonalcoholic fatty liver disease (NAFLD): a “growing” problem?, J Hepatol, 46, 1133, 10.1016/j.jhep.2007.03.003 Dunn, 2008, The obesity epidemic and nonalcoholic fatty liver disease in children, Curr Gastroenterol Rep, 10, 67, 10.1007/s11894-008-0011-1 Boden, 2005, Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver, Diabetes, 54, 3458, 10.2337/diabetes.54.12.3458 Day, 2002, Pathogenesis of steatohepatitis, Best Pract Res Clin Gastroenterol, 16, 663, 10.1053/bega.2002.0333 Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 McCullough, 2006, Pathophysiology of nonalcoholic steatohepatitis, J Clin Gastroenterol, 40, S17 Duvnjak, 2007, Pathogenesis and management issues for non-alcoholic fatty liver disease, World J Gastroenterol, 13, 4539, 10.3748/wjg.v13.i34.4539 Kojima, 2007, Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis, Alcohol Clin Exp Res, 31, S61, 10.1111/j.1530-0277.2006.00288.x Reddy, 2001, Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis, Am J Physiol Gastrointest Liver Physiol, 281, G1333, 10.1152/ajpgi.2001.281.6.G1333 Stienstra, 2007, PPARs, obesity, and inflammation, PPAR Res, 2007, 95974, 10.1155/2007/95974 Lee, 1995, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol Cell Biol, 15, 3012, 10.1128/MCB.15.6.3012 Kersten, 1999, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J Clin Invest, 103, 1489, 10.1172/JCI6223 Mach, 2006, Clinical usefulness of probiotics in inflammatory bowel diseases, J Physiol Pharmacol, 57, 23 Ulisse, 2001, Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment, Am J Gastroenterol, 96, 2691, 10.1111/j.1572-0241.2001.04139.x O’Hara, 2007, Mechanisms of action of probiotics in intestinal diseases, ScientificWorldJournal, 7, 31, 10.1100/tsw.2007.26 Loguercio, 2002, Gut-liver axis: a new point of attack to treat chronic liver damage?, Am J Gastroenterol, 97, 2144, 10.1111/j.1572-0241.2002.05942.x Loguercio, 2005, Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases, J Clin Gastroenterol, 39, 540, 10.1097/01.mcg.0000165671.25272.0f Lirussi, 2007, Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis, Cochrane Database Syst Rev, 1, CD004996 Nanji, 1994, Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease), Proc Soc Exp Biol Med, 205, 243, 10.3181/00379727-205-43703 Solga, 2003, Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics, J Hepatol, 38, 681, 10.1016/S0168-8278(03)00097-7 Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, Hepatology, 37, 343, 10.1053/jhep.2003.50048 Lieber, 2004, Acarbose attenuates experimental non-alcoholic steatohepatitis, Biochem Biophys Res Commun, 315, 699, 10.1016/j.bbrc.2004.01.116 Lieber, 2004, Model of nonalcoholic steatohepatitis, Am J Clin Nutr, 79, 502, 10.1093/ajcn/79.3.502 Guglielmi, 2003, Effect of 4-coumaric and 3,4-dihydroxybenzoic acid on oxidative DNA damage in rat colonic mucosa, Br J Nutr, 89, 10.1079/BJN2003849 Ilagan, 1993, Estimation of body composition changes during weight cycling by bioelectrical impedance analysis in rats, J Appl Physiol, 74, 2092, 10.1152/jappl.1993.74.5.2092 Ferrante, 2002, Effect of fumonisin B1 on structure and function of macrophage plasma membrane, Toxicol Lett, 129, 181, 10.1016/S0378-4274(01)00476-3 Esposito, 2005, Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats, Endocrinology, 146, 3301, 10.1210/en.2005-0375 Okada, 2001, Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer, Biochem Biophys Res Commun, 288, 212, 10.1006/bbrc.2001.5741 Deleve, 2003, Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition, Gastroenterology, 125, 882, 10.1016/S0016-5085(03)01056-4 Loguercio, 2001, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects, J Hepatol, 35, 568, 10.1016/S0168-8278(01)00192-1 Sumida, 2003, Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease, J Hepatol, 38, 32, 10.1016/S0168-8278(02)00331-8 Cortez-Pinto, 2006, Non-alcoholic steatohepatitis: from cell biology to clinical practice, J Hepatol, 44, 197, 10.1016/j.jhep.2005.09.002 Arkan, 2005, IKK-beta links inflammation to obesity-induced insulin resistance, Nat Med, 11, 191, 10.1038/nm1185 Ding, 2004, Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury, J Cell Mol Med, 8, 445, 10.1111/j.1582-4934.2004.tb00469.x Yu, 2006, COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator, Hepatology, 43, 826, 10.1002/hep.21108 Kashireddy, 2004, Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis, Hepatol Res, 30, 104, 10.1016/j.hepres.2004.06.004 Louet, 2001, Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway, Biochem J, 354, 189, 10.1042/bj3540189 Louet, 2001, Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids, Biochem Soc Trans, 29, 310, 10.1042/bst0290310 Le May, 2005, Fatty acids induce L–CPT I gene expression through a PPARalpha-independent mechanism in rat hepatoma cells, J Nutr, 135, 2313, 10.1093/jn/135.10.2313 Shapiro, 1993, Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme-and substrate-specific responses involving prostaglandin-dependent mechanisms, J Biol Chem, 268, 8170, 10.1016/S0021-9258(18)53077-5 Goetzl, 1996, Matrix metalloproteinases in immunity, J Immunol, 156, 1, 10.4049/jimmunol.156.1.1 Xia, 1996, Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane, J Immunol, 156, 160, 10.4049/jimmunol.156.1.160 McGeehan, 1994, Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor, Nature, 370, 558, 10.1038/370558a0 Shibolet, 2002, Variable response to probiotics in two models of experimental colitis in rats, Inflamm Bowel Dis, 8, 399, 10.1097/00054725-200211000-00004 Venturi, 1999, Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis, Aliment Pharmacol Ther, 13, 1103, 10.1046/j.1365-2036.1999.00560.x Bibiloni, 2005, VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis, Am J Gastroenterol, 100, 1539, 10.1111/j.1572-0241.2005.41794.x Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370 Mishra, 2007, Current treatment strategies for non-alcoholic fatty liver disease (NAFLD), Curr Drug Discov Technol, 4, 133, 10.2174/157016307781483469 Mélançon, 2006, Effects of high-sucrose feeding on insulin resistance and hemodynamic responses to insulin in spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol, 290, H2571, 10.1152/ajpheart.01002.2005